Business

Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

(TheNewswire) Toronto, Ontario - TheNewswire - November 3, 2020 ...

articleVentripoint Diagnostics Ltd.November 3, 20204/company/ventripoint-diagnostics-ltd/news/ventripoint-engages-oak-hill-financial-to-provide-investor-relations-services-and-approval-of-warrant-amendment
Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

About this update from Ventripoint Diagnostics Ltd.

[{"type":"text","content":"Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario\n \n \n - TheNewswire\n \n \n - November 3, 2020\n \n \n -\nVentripoint Diagnostics Ltd.\n \n \n (\"\n \n \n Ventripoint\n \n \n \" or\nthe \"\n \n \n Company\n \n \n \"), (TSXV:VPT)\n \n \n (OTC:VPTDF)\n \n \n is pleased to announce that, subject to TSXV approval,\nit has engaged Oak Hill Financial Inc. (\"Oak Hill\"), a\nToronto-based investor relations firm, to provide market awareness and\ninvestor relations services to the Company in compliance with TSXV\npolicies. Jonathan Robinson is a partner with Oak Hill and will be\nresponsible for activities related to Ventripoint.\n \n \n \n \n Oak Hill is a leading investor and financial advisory\nfirm specializing in small cap companies. Oak Hill will increase\nawareness about\n \n \n Ventripoint\n \n \n through its established relationships with investment\nprofessionals, investment advisors, and money managers focused on the\nsmall- and micro-cap market space. This will allow the Company to\nbuild and maintain an informed investor audience in the Canadian\nmarketplace.\n \n \n \n \n \n \n Oak Hill will receive\nC$6,500 per month during the initial three-month term of the\nagreement.\n \n \n The Company\n \n \n has\nalso agreed to a one-time grant of 500,000 incentive stock options\n(the \"Options\") exercisable at a price of C$0.11 share\nexercisable for a period of 18 months. The Options will be subject to\nthe terms of the Company's stock option plan and will vest in\naccordance with the provisions therein and the policies of the\nTSX-V.\n \n \n \n \n Oak Hill currently has no direct or indirect interest\nin the securities of\n \n \n Ventripoint\n \n \n , or any right or intent to acquire such an interest except\npursuant to the exercise of the above referenced Options.\n \n \n \n \n The appointment of Oak Hill as an investor relations\nconsultant of\n \n \n Ventripoint\n \n \n and the granting of the Options remain subject to regulatory\nacceptance of applicable filings with the TSXV.\n \n \n \n \n In other news, The Company has received final approval\nfrom the\n \n \n TSXV to amend the exercise price of\n \n \n common share purchase warrants originally issued\non October 2, 2019.\n \n \n \n ...

More updates from Ventripoint Diagnostics Ltd.